Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q80605580)
Watch
English
Expanded phase II trial of gemcitabine and capecitabine for advanced biliary cancer
scientific article published on 01 September 2007
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
17628484
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17628484%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 January 2020
title
Expanded phase II trial of gemcitabine and capecitabine for advanced biliary cancer
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
17628484
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17628484%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 January 2020
main subject
phase II clinical trial
1 reference
based on heuristic
inferred from title
capecitabine
1 reference
based on heuristic
inferred from title
author name string
Rachel P Riechelmann
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
17628484
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17628484%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 January 2020
Carol A Townsley
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
17628484
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17628484%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 January 2020
Sheray N Chin
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed publication ID
17628484
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17628484%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 January 2020
Gregory R Pond
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed publication ID
17628484
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17628484%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 January 2020
Jennifer J Knox
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed publication ID
17628484
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17628484%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 January 2020
publication date
1 September 2007
1 reference
stated in
Europe PubMed Central
PubMed publication ID
17628484
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17628484%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 January 2020
published in
Cancer
1 reference
stated in
Europe PubMed Central
PubMed publication ID
17628484
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17628484%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 January 2020
volume
110
1 reference
stated in
Europe PubMed Central
PubMed publication ID
17628484
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17628484%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 January 2020
issue
6
1 reference
stated in
Europe PubMed Central
PubMed publication ID
17628484
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17628484%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 January 2020
page(s)
1307-1312
1 reference
stated in
Europe PubMed Central
PubMed publication ID
17628484
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17628484%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 January 2020
cites work
Cholangiocarcinoma.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.22902
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Worldwide trends in mortality from biliary tract malignancies
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.22902
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Eastern cooperative oncology group experience with chemotherapy for inoperable gallbladder and bile duct cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.22902
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.22902
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Gallbladder cancer, a different disease that needs individual trials
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.22902
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Combination chemotherapy with gemcitabine and cisplatin as first-line treatment for immunohistochemically proven cholangiocarcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.22902
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II study of capecitabine plus cisplatin as first-line chemotherapy in advanced biliary cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.22902
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Oxaliplatin, fluorouracil and leucovorin for advanced biliary system adenocarcinomas: a prospective phase II trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.22902
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.22902
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.22902
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II study of erlotinib in patients with advanced biliary cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.22902
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Capecitabine combined with gemcitabine (CapGem) as first-line treatment in patients with advanced/metastatic biliary tract carcinoma.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.22902
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Gemcitabine and cisplatin combination chemotherapy in intrahepatic cholangiocarcinoma as second-line treatment: report of four cases
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.22902
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Mitomycin C in combination with capecitabine or biweekly high-dose gemcitabine in patients with advanced biliary tract cancer: a randomised phase II trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.22902
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomised phase II trial of weekly high-dose 5-fluorouracil with and without folinic acid and cisplatin in patients with advanced biliary tract carcinoma: results of the 40955 EORTC trial.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.22902
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase III study of 5FU, etoposide and leucovorin (FELV) compared to epirubicin, cisplatin and 5FU (ECF) in previously untreated patients with advanced biliary cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.22902
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A phase II study of gemcitabine in gallbladder carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.22902
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Optimization of 5-fluorouracil (5-FU)/cisplatin combination chemotherapy with a new schedule of leucovorin, 5-FU and cisplatin (LV5FU2-P regimen) in patients with biliary tract carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.22902
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Outpatient therapy with gemcitabine and docetaxel for gallbladder, biliary, and cholangio-carcinomas
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.22902
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A Phase II trial of fixed dose rate gemcitabine in patients with advanced biliary tree carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.22902
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1002/CNCR.22902
1 reference
stated in
Europe PubMed Central
PubMed publication ID
17628484
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17628484%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 January 2020
PubMed publication ID
17628484
1 reference
stated in
Europe PubMed Central
PubMed publication ID
17628484
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17628484%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 January 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit